Laursen I - Search Results

1

Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia.

Frakking FN, Brouwer N, van de Wetering MD, Budde IK, Strengers PF, Huitema AD, Laursen I, Houen G, Caron HN, Dolman KM, Kuijpers TW. Frakking FN, et al. Among authors: laursen i. Eur J Cancer. 2009 Mar;45(4):505-12. doi: 10.1016/j.ejca.2008.11.036. Epub 2008 Dec 31. Eur J Cancer. 2009. PMID: 19121580 Clinical Trial.

2

Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels.

Brouwer N, Frakking FN, van de Wetering MD, van Houdt M, Hart M, Budde IK, Strengers PF, Laursen I, Houen G, Roos D, Jensenius JC, Caron HN, Dolman KM, Kuijpers TW. Brouwer N, et al. Among authors: laursen i. J Immunol. 2009 Sep 1;183(5):3496-504. doi: 10.4049/jimmunol.0900445. Epub 2009 Aug 5. J Immunol. 2009. PMID: 19657091

3

MASP interactions with plasma-derived MBL.

Laursen IA, Thielens NM, Christiansen M, Houen G. Laursen IA, et al. Mol Immunol. 2012 Sep;52(2):79-87. doi: 10.1016/j.molimm.2012.04.014. Epub 2012 May 18. Mol Immunol. 2012. PMID: 22607836

4

Characterisation of the 1st SSI purified MBL standard.

Laursen I, Højrup P, Houen G, Christiansen M. Laursen I, et al. Clin Chim Acta. 2008 Sep;395(1-2):159-61. doi: 10.1016/j.cca.2008.06.006. Epub 2008 Jun 12. Clin Chim Acta. 2008. PMID: 18593571

5

Second-generation nanofiltered plasma-derived mannan-binding lectin product: process and characteristics.

Laursen I, Houen G, Højrup P, Brouwer N, Krogsøe LB, Blou L, Hansen PR. Laursen I, et al. Vox Sang. 2007 May;92(4):338-50. doi: 10.1111/j.1423-0410.2007.00901.x. Vox Sang. 2007. PMID: 17456158

6

The chaperone and potential mannan-binding lectin (MBL) co-receptor calreticulin interacts with MBL through the binding site for MBL-associated serine proteases.

Pagh R, Duus K, Laursen I, Hansen PR, Mangor J, Thielens N, Arlaud GJ, Kongerslev L, Højrup P, Houen G. Pagh R, et al. Among authors: laursen i. FEBS J. 2008 Feb;275(3):515-26. doi: 10.1111/j.1742-4658.2007.06218.x. Epub 2008 Jan 3. FEBS J. 2008. PMID: 18177377 Free article.

7

Safety pharmacology, toxicology and pharmacokinetic assessment of human Gc globulin (vitamin D binding protein).

Pihl TH, Jørgensen CS, Santoni-Rugiu E, Leifsson PS, Hansen EW, Laursen I, Houen G. Pihl TH, et al. Among authors: laursen i. Basic Clin Pharmacol Toxicol. 2010 Nov;107(5):853-60. doi: 10.1111/j.1742-7843.2010.00587.x. Basic Clin Pharmacol Toxicol. 2010. PMID: 20560927 Free article.

8

Interaction of C1q with the receptor calreticulin requires a conformational change in C1q.

Steinø A, Jørgensen CS, Laursen I, Houen G. Steinø A, et al. Among authors: laursen i. Scand J Immunol. 2004 May;59(5):485-95. doi: 10.1111/j.0300-9475.2004.01425.x. Scand J Immunol. 2004. PMID: 15140059 Free article.

9

Large-scale purification and characterization of non-glycosylated Gc globulin (vitamin D-binding protein) from plasma fraction IV.

Jørgensen CS, Christiansen M, Laursen I, Krogsøe LB, Højrup P, Blou L, Houen G. Jørgensen CS, et al. Among authors: laursen i. Biotechnol Appl Biochem. 2006 Apr;44(Pt 1):35-44. doi: 10.1042/BA20050209. Biotechnol Appl Biochem. 2006. PMID: 16402919

10

Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study.

Valdimarsson H, Vikingsdottir T, Bang P, Saevarsdottir S, Gudjonsson JE, Oskarsson O, Christiansen M, Blou L, Laursen I, Koch C. Valdimarsson H, et al. Among authors: laursen i. Scand J Immunol. 2004 Jan;59(1):97-102. doi: 10.1111/j.0300-9475.2004.01357.x. Scand J Immunol. 2004. PMID: 14723627 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page